| 2922.50.07 | 00 | 3,4-Diaminophenetole dihydrogen sulfate; 2-Nitro-5-[(2,3-dihydroxy)propoxy]-￠/methylaniline; 2-Nitro-5-(2-hydroxyethoxy)-N-methylaniline; 4-(2-Hydroethoxy)-1,3-phenylenediamine dihydrochloride; 3-Methoxy-4-[(2-hydroxyethyl)amino]nitro- benzene; 4-[(2-Hydroxyethyl)amino]-3-nitrophenol; and ￠/- α-Amino-4-hydroxybenzeneacetic acid (d(-)-p-Hydroxyphenylglycine) | kg | Free | | 15.4￠/kg + 50% |
| 2922.50.10 | 00 | dl-3-(3,4-Dihydroxyphenyl)alanine; N-Ethyl-N-(2-methoxycarbonylethyl)aniline; dl-Phenylephrine base; and Carbonic acid, methyl ester, diester with 2,2'-(m-tolylamino)diethanol (Toluidine carbonate) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.50.11 | 00 | Salts of d(-)-p-Hydroxyphenylglycine (￠/- α-Amino-4-hydroxybenzeneacetic acid) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 50% |
| 2922.50.13 | 00 | Isoetharine hydrochloride; Isoxsuprine hydrochloride; Nylidrin hydrochloride; Phenylephrine hydrochloride; Salbutamol (Albuterol); and Terbutaline sulfate | kg | Free | | 15.4￠/kg + 47% |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924.12.00 | 00 | Fluoroacetamide (ISO), monocrotophos (ISO) and phosphamidon (ISO) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.19.11 | 30 | Methacrylamide | kg | | | |
| 2924.21.08 | 00 | 1,1-Dimethyl-3-( α, α, α-trifluoro-￠/tolyl)urea (Fluometuron) | kg | Free | | 15.4￠/kg + 40.5% |
| 2924.29.23 | 00 | 4-Aminoacetanilide; 2,2'-Oxamidobis[ethyl-3-(3,5-di-tert-butyl- 4-hydroxyphenyl)propionate]; Acetoacetsulfanilic acid, potassium salt; and N-(2,3-Dihydroxypropyl)-5-N-(2,3-dihydroxy- propyl)acetamido-N'-(2-hydroxyethyl)- 2,4,6-triiodoisophthalamide | kg | Free | | 15.4￠/kg + 58% |
| 2924.29.31 | 00 | 4-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-￠/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamide | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2924.29.33 | 00 | 3-Hydroxy-2-naphthanilide; 3-Hydroxy-2-naphtho-o-toluidide; 3-Hydroxy-2-naphtho-o-anisidine; 3-Hydroxy-2-naphtho-o-phenetidide; 3-Hydroxy-2-naphtho-4-chloro-2,5- dimethoxyanilide; 3-Hydroxy-3'-nitro-2-naphthanilide; and N,N'-Bis(acetoacetyl-o-toluidine) | kg | Free | | 15.4￠/kg + 60% |
| 2924.29.43 | 00 | 3-Ethoxycarbonylaminophenyl-￠/phenylcarbamate (Desmedipham); and Isopropyl-N-(3-chlorophenyl)car- bamate (CIPC) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 40.5% |
| 2925 | | Carboxyimide-function compounds (including saccharin and its salts) and imine-function compounds: | | | | |
| 2925.11.00 | 00 | Saccharin and its salts | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 61% |
| 2925.19.10 | 00 | Ethylenebistetrabromophthalimide | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P) 3% (SG) | 15.4￠/kg + 61% |
| 2925.29.18 | 00 | N,N'-Diphenylguanidine; 3-Dimethylaminomethyleneiminophenol hydrochloride; 1,3-Di-o-tolylguanidine; and N,N-Dimethyl-N'-[3-[[(methylamino)carbonyl]- oxy]phenyl]methanimidamide monohydro- chloride | kg | Free | | 15.4￠/kg + 61% |
| 2926.30 | | Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane): | | | | |
| 2926.90.05 | 00 | 2-Amino-4-chlorobenzonitrile (5-Chloro-2- cyanoaniline); 2-Amino-5-chlorobenzonitrile; 4-Amino-2-chlorobenzonitrile; (Cyanoethyl)(hydroxyethyl)-m-toluidine; p-Cyanophenyl acetate; Phthalonitrile; and Tetrachloro-3-cyanobenzoic acid, methyl ester | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 41% |
| 2926.90.16 | 00 | [1 α(S*),3 α(Z)]-( ± )-Cyano(3-phenoxyphenyl)- methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)- 2,2-dimethylcyclopropanecarboxylate | kg | Free | | 15.4￠/kg + 64.5% |
| 2927.00.18 | 00 | 1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5-oxo, ester with phenyl(2,3,4-trihydroxyphenyl)methanone; 1-Naphthalenesulfonic acid, 3-diazo-3,4-dihydro-4- oxo-ar'-(1-methylethyl)[1,1'-biphenyl]-4-yl ester; 1-Napthanlenesulfonic acid, 6-diazo-5,6-dihydro-5- oxo-,(octahydro-4,7-methano-1H-indene-2,5-diyl)bis- (methylene) ester; and 1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5- oxo-, 4-benzoyl-1,2,3-benzenetriyl ester | kg | Free | | 15.4￠/kg + 50% |
| 2929.10.27 | 00 | N-Butylisocyanate; Cyclohexyl isocyanate; 1-Isocyanato-3-(trifluoromethyl)benzene; 1,5-Naphthalene diisocyanate; and Octadecyl isocyanate | kg | Free | | 15.4￠/kg + 52% |
| 2929.90.50 | 10 | N,N-Dialkyl (methyl, ethyl, n-propyl or isopropyl)phosphoramidic dihalides | kg | | | |
| 2930.50.00 | 00 | Captafol (ISO) and methamidophos (ISO) | kg | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, MA,MX,P,SG) | 30.5% |
| 2930.90.24 | 00 | N-Cyclohexylthiophthalimide | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 40.5% |
| 2930.90.26 | 00 | 3-(4'-Aminobenzamido)phenyl-￠/hydroxy- ethylsulfone; 2-[(4-Aminophenyl)sulfonyl]ethanol, hydrogen sulfate ester; Diphenylthiourea; N,N'-(Dithiodi-2,1-phenylene)bisbenzamide; Pentachlorothiophenol; and 4,4'-Thiodiphenyl cyanate | kg | Free | | 15.4￠/kg + 40.5% |
